8-KEarnings & ResultsRegulation FDExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Oct 27, 2021)

Filed October 27, 2021For Securities:BMYCELG-RIBMYMP

Summary

Bristol Myers Squibb (BMY) filed an 8-K on October 27, 2021, to announce its third-quarter 2021 financial results and related operational initiatives. The filing includes the official earnings press release, supplemental financial information, and a presentation covering financial and operating updates. Investors should note that this report primarily serves to furnish these materials and does not contain new material events beyond the Q3 earnings announcement itself. The company emphasizes that some of the presented information, particularly in the supplemental materials and presentation, may include non-GAAP financial measures, with reconciliations provided for transparency.

Key Highlights

  • 1Announcement of Third Quarter 2021 financial results via press release (Exhibit 99.1).
  • 2Furnishing of supplemental financial information available on the company's website (Exhibit 99.2).
  • 3Presentation of financial and operating initiatives also posted on the company's website (Exhibit 99.3).
  • 4The filing includes references to non-GAAP financial information, with reconciliations available in supplemental materials.
  • 5The company hosted a conference call and webcast on October 27, 2021, to discuss these results and initiatives.
  • 6Information furnished under Item 7.01 is not considered 'filed' for certain regulatory purposes.

Frequently Asked Questions